Anne C. Goldberg

20.8k total citations · 9 hit papers
122 papers, 15.5k citations indexed

About

Anne C. Goldberg is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, Anne C. Goldberg has authored 122 papers receiving a total of 15.5k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Surgery, 49 papers in Endocrinology, Diabetes and Metabolism and 34 papers in Economics and Econometrics. Recurrent topics in Anne C. Goldberg's work include Lipoproteins and Cardiovascular Health (94 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (42 papers) and Health Systems, Economic Evaluations, Quality of Life (27 papers). Anne C. Goldberg is often cited by papers focused on Lipoproteins and Cardiovascular Health (94 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (42 papers) and Health Systems, Economic Evaluations, Quality of Life (27 papers). Anne C. Goldberg collaborates with scholars based in United States, United Kingdom and Italy. Anne C. Goldberg's co-authors include Jennifer G. Robinson, Neil J. Stone, Peter W.F. Wilson, Karol E. Watson, Robert H. Eckel, David Gordon, Donald M. Lloyd‐Jones, Conrad B. Blum, Alice H. Lichtenstein and Patrick E. McBride and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Anne C. Goldberg

118 papers receiving 14.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

2013 5.5k citations Neil J. Stone, Jennifer G. Robinson et al. Circulation profile →
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

2013 2.9k citations Neil J. Stone, Jennifer G. Robinson et al. Journal of the American College of Cardiology profile →
Triglycerides and Cardiovascular Disease

2011 1.4k citations Neil J. Stone, Christie M. Ballantyne et al. Circulation profile →
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline

2012 588 citations Anne C. Goldberg et al. profile →
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

2011 465 citations Anne C. Goldberg, Peter P. Tóth et al. Journal of clinical lipidology profile →
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

2011 397 citations Anne C. Goldberg, Peter P. Tóth et al. Journal of clinical lipidology profile →
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease

2019 324 citations Anne C. Goldberg, Lawrence A. Leiter et al. profile →
Sex Differences in the Use of Statins in Community Practice

2019 197 citations Anne C. Goldberg, Jennifer G. Robinson et al. profile →
Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial

2025 17 citations Anne C. Goldberg, Douglas Kling et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne C. Goldberg United States	38	10.0k	5.2k	4.5k	3.5k	1.8k	122	15.5k
Terry A. Jacobson United States	70	9.1k 0.9×	4.8k 0.9×	3.5k 0.8×	2.8k 0.8×	1.6k 0.9×	218	17.3k
Colin Baigent United Kingdom	51	11.0k 1.1×	4.7k 0.9×	8.9k 2.0×	3.7k 1.0×	2.0k 1.1×	136	22.6k
Ole Færgeman Denmark	41	9.9k 1.0×	5.6k 1.1×	5.1k 1.1×	2.8k 0.8×	2.3k 1.2×	191	16.3k
Stuart M. Cobbe United Kingdom	49	9.1k 0.9×	4.7k 0.9×	6.5k 1.5×	3.1k 0.9×	1.7k 0.9×	160	18.1k
Željko Reiner Croatia	47	6.8k 0.7×	3.7k 0.7×	3.8k 0.8×	1.8k 0.5×	1.6k 0.9×	265	13.3k
Jean MacFadyen United States	42	8.1k 0.8×	3.3k 0.6×	4.1k 0.9×	2.0k 0.6×	1.5k 0.8×	56	15.3k
Peter P. Tóth United States	68	8.4k 0.8×	5.4k 1.1×	3.9k 0.9×	1.8k 0.5×	2.2k 1.2×	529	16.7k
Robert S. Rosenson United States	61	8.7k 0.9×	4.8k 0.9×	5.1k 1.1×	1.8k 0.5×	2.2k 1.2×	386	16.6k
Helen M. Colhoun United Kingdom	65	8.0k 0.8×	8.8k 1.7×	4.2k 0.9×	2.4k 0.7×	1.2k 0.7×	278	19.3k
Anthony Keech Australia	66	14.3k 1.4×	7.3k 1.4×	6.6k 1.5×	4.7k 1.3×	2.9k 1.6×	298	23.8k

Countries citing papers authored by Anne C. Goldberg

Since Specialization

Citations

This map shows the geographic impact of Anne C. Goldberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne C. Goldberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne C. Goldberg more than expected).

Fields of papers citing papers by Anne C. Goldberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne C. Goldberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne C. Goldberg. The network helps show where Anne C. Goldberg may publish in the future.

Co-authorship network of co-authors of Anne C. Goldberg

This figure shows the co-authorship network connecting the top 25 collaborators of Anne C. Goldberg. A scholar is included among the top collaborators of Anne C. Goldberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne C. Goldberg. Anne C. Goldberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nicholls, Stephen C., Adam Nelson, Marc Ditmarsch, et al.. (2025). † Safety and efficacy of obicetrapib in patients with heterozygous familial hypercholesterolemia. Journal of clinical lipidology. 19(3). e91–e91. 1 indexed citations

Russell, David, Yashika Sharma, Andrew P. Ambrosy, et al.. (2024). Stakeholder Perspectives on the Meaningful Integration of Clinical Informatics Interventions Using Patient-Reported Outcomes in Healthcare. SHILAP Revista de lepidopterología. 8(2). e79–e88. 1 indexed citations

Duell, P. Barton, Maciej Banach, Alberico L. Catapano, et al.. (2024). Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials. Journal of clinical lipidology. 18(2). e153–e165. 2 indexed citations

Goldberg, Anne C., Maciej Banach, Alberico L. Catapano, et al.. (2023). Evaluation of the efficacy and safety of bempedoic acid in women and men: Pooled analyses from phase 3 trials. Atherosclerosis. 384. 117192–117192. 5 indexed citations

Goldberg, Anne C., et al.. (2022). Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know. Current Atherosclerosis Reports. 24(8). 619–625. 5 indexed citations

Ballantyne, Christie M., Harold Bays, Alberico L. Catapano, et al.. (2021). Role of Bempedoic Acid in Clinical Practice. Cardiovascular Drugs and Therapy. 35(4). 853–864. 97 indexed citations

Ballantyne, Christie M., Harold Bays, Alberico L. Catapano, et al.. (2021). Correction to: Role of Bempedoic Acid in Clinical Practice. Cardiovascular Drugs and Therapy. 35(4). 865–865. 1 indexed citations

Agarwala, Anandita, Elena Deych, Michael W. Rich, et al.. (2021). Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia. Journal of the American Heart Association. 10(17). e020890–e020890. 13 indexed citations

Peterson, Linda R., Xuntian Jiang, Ling Chen, et al.. (2020). Alterations in plasma triglycerides and ceramides: links with cardiac function in humans with type 2 diabetes. Journal of Lipid Research. 61(7). 1065–1074. 18 indexed citations

10.

Goldberg, Anne C., et al.. (2018). Mipomersen and its use in familial hypercholesterolemia. Expert Opinion on Pharmacotherapy. 20(2). 127–131. 69 indexed citations

11.

Roth, Eli M., Anne C. Goldberg, Alberico L. Catapano, et al.. (2016). IMPACT OF ANTI-DRUG ANTIBODIES TO ALIROCUMAB ON LDL-C LOWERING EFFICACY AND SAFETY. Journal of the American College of Cardiology. 67(13). 1863–1863. 2 indexed citations

12.

Brown, W. Virgil, Daniel J. Rader, & Anne C. Goldberg. (2013). JCL Roundtable: Drug treatment of severe forms of familial hypercholesterolemia. Journal of clinical lipidology. 8(1). 10–17. 6 indexed citations

13.

Stone, Neil J., Jennifer G. Robinson, Alice H. Lichtenstein, et al.. (2013). 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. Circulation. 129(25_suppl_2). 2889–45. 5491 indexed citations breakdown →

14.

Robinson, Jennifer G. & Anne C. Goldberg. (2011). Treatment of adults with Familial Hypercholesterolemia and evidence for treatment: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Journal of clinical lipidology. 5(3). S18–S29. 91 indexed citations

15.

Goldberg, Anne C., Vera Bittner, Carl J. Pepine, et al.. (2011). Efficacy of Fenofibric Acid Plus Statins on Multiple Lipid Parameters and Its Safety in Women With Mixed Dyslipidemia. The American Journal of Cardiology. 107(6). 898–905. 9 indexed citations

16.

Goldberg, Anne C., et al.. (2011). NLA Recommendations for the Diagnosis and Management of Familial Hypercholesterolemia in Children and Adults. Journal of clinical lipidology. 5(6). S2–S3. 1 indexed citations

17.

Goldberg, Anne C., Harold Bays, Christie M. Ballantyne, et al.. (2008). Efficacy and Safety of ABT-335 (Fenofibric Acid) in Combination With Atorvastatin in Patients With Mixed Dyslipidemia. The American Journal of Cardiology. 103(4). 515–522. 58 indexed citations

18.

Goldberg, Anne C.. (1997). The impact of lipid lowering in coronary artery disease. Current Opinion in Cardiology. 12(5). 488–493. 2 indexed citations

19.

Gotto, Antonio M., William J. Breen, Clinton N. Corder, et al.. (1993). Once-daily, extended-release gemfibrozil in patients with dyslipidemia. The American Journal of Cardiology. 71(12). 1057–1063. 10 indexed citations

20.

Goldberg, Anne C., et al.. (1987). Fenofibrate affects the compositions of lipoproteins. The American Journal of Medicine. 83(5). 60–65. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact